» Articles » PMID: 19304953

Overexpression of Astrocyte Elevated Gene-1 (AEG-1) is Associated with Esophageal Squamous Cell Carcinoma (ESCC) Progression and Pathogenesis

Overview
Journal Carcinogenesis
Specialty Oncology
Date 2009 Mar 24
PMID 19304953
Citations 95
Authors
Affiliations
Soon will be listed here.
Abstract

Astrocyte elevated gene-1 (AEG-1), upregulated in various types of human cancers, has been reported to be associated with the carcinogenesis of human cancer. However, the functional significance of AEG-1 in human esophageal squamous cell carcinoma (ESCC) remains unknown. In the present study, we showed the expression of AEG-1 was markedly upregulated in esophageal cancer cell lines and surgical ESCC specimens at both transcriptional and translational levels. Immunohistochemical analysis revealed that 80 of 168 (47.6%) paraffin-embedded archival ESCC specimens exhibited high levels of AEG-1 expression. Statistical analysis suggested the upregulation of AEG-1 was significantly correlated with the clinical staging of the ESCC patients (P = 0.001), T classification (P = 0.002), N classification (P = 0.034), M classification (P = 0.021) and histological differentiation (P = 0.035) and those patients with high AEG-1 levels exhibited shorter survival time (P < 0.001). Multivariate analysis indicated that AEG-1 expression might be an independent prognostic indicator of the survival of patients with ESCC. Furthermore, we found that ectopic expression of AEG-1 in ESCC cells could significantly enhance cell proliferation and anchorage-independent growth ability. Conversely, silencing AEG-1 by short hairpin RNAi caused an inhibition of cell growth and anchorage-independent growth ability on soft agar. Moreover, we demonstrated that the upregulation of AEG-1 could reduce the expression of p27(Kip1) and induce the expression of cyclin D1 through the AKT/FOXO3a pathway. Our findings suggest that the AEG-1 protein is a valuable marker of ESCC progression and that the upregulation of AEG-1 plays an important role in the development and pathogenesis of human ESCC.

Citing Articles

Involvement of circRNA Regulators MBNL1 and QKI in the Progression of Esophageal Squamous Cell Carcinoma.

Wang H, Zhou X, Zhang Q, Wu J, Hou J, Xu X Cancer Control. 2024; 31:10732748241257142.

PMID: 38769028 PMC: 11107321. DOI: 10.1177/10732748241257142.


Roles and Molecular Mechanisms of Biomarkers in Hepatocellular Carcinoma with Microvascular Invasion: A Review.

Zhao X, Wang Y, Xia H, Liu S, Huang Z, He R J Clin Transl Hepatol. 2023; 11(5):1170-1183.

PMID: 37577231 PMC: 10412705. DOI: 10.14218/JCTH.2022.00013S.


Transcriptome analysis in an AEG‑1‑deficient neuronal HT22 cell line.

Liu K, Wan P, Huang Y, Wang B, Wang X, Zhang R Exp Ther Med. 2022; 24(5):670.

PMID: 36237597 PMC: 9500495. DOI: 10.3892/etm.2022.11607.


METTL1 promotes neuroblastoma development through mG tRNA modification and selective oncogenic gene translation.

Huang Y, Ma J, Yang C, Wei P, Yang M, Han H Biomark Res. 2022; 10(1):68.

PMID: 36071474 PMC: 9454133. DOI: 10.1186/s40364-022-00414-z.


Retracted Article: Long non-coding RNA PCAT1 facilitates cell growth in multiple myeloma through an MTDH-mediated AKT/β-catenin signaling pathway by sponging miR-363-3p.

Chen Y, Hao J, Zhao J, Liu Y, Li Y, Ren J RSC Adv. 2022; 9(58):33834-33842.

PMID: 35528923 PMC: 9073615. DOI: 10.1039/c9ra06188f.